An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management
Domains
Human health and pathologyOrigin | Files produced by the author(s) |
---|
Origin | Files produced by the author(s) |
---|
Accord Elsevier CCSD : Connect in order to contact the contributor
https://hal.univ-lorraine.fr/hal-03504767
Submitted on : Monday, January 8, 2024-8:05:46 AM
Last modification on : Saturday, January 18, 2025-12:29:25 PM